{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T08:45:16Z","timestamp":1759481116549},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.diagmicrobio.2009.11.011","type":"journal-article","created":{"date-parts":[[2010,3,11]],"date-time":"2010-03-11T09:56:13Z","timestamp":1268301373000},"page":"385-392","source":"Crossref","is-referenced-by-count":8,"title":["Chlamydia pneumoniae IgG and IgA antibody titers and prognosis in patients with coronary heart disease: results from the CLARICOR trial"],"prefix":"10.1016","volume":"66","author":[{"given":"J\u00f8rgen","family":"Hilden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inga","family":"Lind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans J\u00f8rn","family":"Kolmos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bodil","family":"Als-Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten","family":"Damgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f8rgen Fischer","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stig","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olav H.","family":"Hel\u00f8","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Hildebrandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gorm Boje","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Kastrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Kj\u00f8ller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian M.","family":"Jespersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Gluud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2009.11.011_bib1","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMe058019","article-title":"Infection, antibiotics and atherothrombosis\u2014end of the road or new beginnings","volume":"352","author":"Anderson","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.diagmicrobio.2009.11.011_bib2","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1161\/01.CIR.99.12.1540","volume":"99","author":"Anderson","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.diagmicrobio.2009.11.011_bib3","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1161\/01.STR.0000201970.88546.5e","article-title":"Chlamydia pneumoniae, stroke, and serological associations. Anything learned from the atherosclerosis\u2013cardiovascular literature or do we have to start over again?","volume":"37","author":"Apfalter","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.diagmicrobio.2009.11.011_bib4","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1086\/428730","article-title":"Association between Chlamydia pneumoniae and acute myocardial infarction in young men in the United States military: the importance of timing of exposure measurement","volume":"40","author":"Arcari","year":"2005","journal-title":"CID"},{"key":"10.1016\/j.diagmicrobio.2009.11.011_bib5","unstructured":"Bennedsen M., (2003) Chlamydia pneumoniae. Assessment of the microimmunofluorescence test for antibody detection and prevalence studies in adult patients with respiratory tract infection. Thesis. University of Copenhagen, Copenhagen, Denmark."},{"key":"10.1016\/j.diagmicrobio.2009.11.011_bib6","first-page":"833","article-title":"Performance of three microimmunofluorescence assays for detection of Chlamydia pneumoniae immunoglobulin M, G and A antibodies.","volume":"9","author":"Bennedsen","year":"2002","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.diagmicrobio.2009.11.011_bib7","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1128\/CDLI.10.4.525-528.2003","article-title":"Effect of clarithromycin on inflammatory markers in patients with atherosclerosis","volume":"10","author":"Berg","year":"2003","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.diagmicrobio.2009.11.011_bib8","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1128\/JCM.43.3.1325-1329.2005","article-title":"Effect of clarithromycin treatment on Chlamydia pneumoniae in vascular tissue of patients with coronary artery disease: a randomized, double-blind, placebo-controlled trial","volume":"43","author":"Berg","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2009.11.011_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.15.1.1-20.2002","article-title":"Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies","volume":"15","author":"Boman","year":"2002","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.diagmicrobio.2009.11.011_bib10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000128993","article-title":"Increased risk of mortality following antibiotic treatment in patients with coronary artery disease?","volume":"111","author":"Cercek","year":"2008","journal-title":"Cardiology"},{"key":"10.1016\/j.diagmicrobio.2009.11.011_bib11","first-page":"66","article-title":"Antibodies to 60-kiloDalton heat shock protein and outer membrane protein 2 of Chlamydia pneumoniae in patients with coronary heart disease","volume":"9","author":"Ciervo","year":"2002","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.diagmicrobio.2009.11.011_bib12","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/bmj.321.7255.208","article-title":"Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis","volume":"321","author":"Danesh","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.diagmicrobio.2009.11.011_bib13","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1053\/euhj.2001.2801","article-title":"Chlamydia pneumoniae IgA titres and coronary heart disease. Prospective study and meta-analysis","volume":"23","author":"Danesh","year":"2002","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.diagmicrobio.2009.11.011_bib14","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1086\/322632","article-title":"Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada)","volume":"33","author":"Dowell","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2009.11.011_bib15","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/01.STR.0000202624.89869.e9","article-title":"Seropositivity to Chlamydia pneumoniae is associated with risk of first ischemic stroke","volume":"37","author":"Elkind","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.diagmicrobio.2009.11.011_bib16","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1161\/01.STR.30.10.2013","article-title":"Chlamydia pneumoniae antibodies and high lipoprotein(a) levels do not predict ischemic cerebral infarctions. Results from a nested case-control study in Northern Sweden","volume":"30","author":"Glader","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.diagmicrobio.2009.11.011_bib17","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000128994","article-title":"Clarithromycin for 2 weeks for stable coronary heart disease: 6-year follow-up of the CLARICOR randomized trial and updated meta-analysis of antibiotics for coronary heart disease","volume":"111","author":"Gluud","year":"2008","journal-title":"Cardiology"},{"key":"10.1016\/j.diagmicrobio.2009.11.011_bib18","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1161\/01.CIR.96.2.404","article-title":"Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction","volume":"96","author":"Gupta","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.diagmicrobio.2009.11.011_bib19","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0140-6736(97)07201-2","article-title":"Randomised trial of roxithromycin in non\u2013Q-wave coronary syndromes: ROXIS Pilot Study","volume":"350","author":"Gurfinkel","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.diagmicrobio.2009.11.011_bib20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000022705","article-title":"Intervention with clarithromycin in patients with stable coronary disease. The CLARICOR trial design.","volume":"1","author":"Hansen","year":"2001","journal-title":"Heart Drug"},{"key":"10.1016\/j.diagmicrobio.2009.11.011_bib21","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"NEJM"},{"key":"10.1016\/j.diagmicrobio.2009.11.011_bib22","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2143\/AC.62.6.2024015","article-title":"Chlamydia pneumoniae-based atherosclerosis: a smoking gun","volume":"62","author":"Hoymans","year":"2007","journal-title":"Acta Cardiol."},{"key":"10.1016\/j.diagmicrobio.2009.11.011_bib23","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijcard.2006.12.010","article-title":"Implications of antibodies to heat-shock proteins in ischemic heart disease","volume":"123","author":"Hoymans","year":"2008","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.diagmicrobio.2009.11.011_bib24","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1086\/315442","article-title":"Antibody response to the 60-kDa heat\u2013shock protein of Chlamydia pneumoniae in patients with coronary artery disease","volume":"181","author":"Jantos","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2009.11.011_bib25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/bmj.38666.653600.55","article-title":"Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial","volume":"332","author":"Jespersen","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.diagmicrobio.2009.11.011_bib26","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1093\/ije\/23.6.1315","article-title":"Importance of smoking for Chlamydia pneumoniae seropositivity","volume":"23","author":"Karvonen","year":"1994","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.diagmicrobio.2009.11.011_bib27","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/eurheartj\/ehp049","article-title":"High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary heart disease","volume":"30","author":"Kastrup","year":"2009","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.diagmicrobio.2009.11.011_bib28","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1161\/01.CIR.0000031567.10814.D8","article-title":"Serum immunoglobulin G antibodies to chlamydial heat shock protein 60 but not to human and bacterial homologs are associated with coronary heart disease","volume":"106","author":"Mahdi","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.diagmicrobio.2009.11.011_bib29","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1086\/514570","article-title":"Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke","volume":"26","author":"Mattila","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2009.11.011_bib30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.diagmicrobio.2006.04.007","article-title":"Chlamydia pneumoniae antibody levels before coronary events in the Helsinki Heart Study as measured by different methods","volume":"56","author":"Paldanius","year":"2006","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2009.11.011_bib31","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(88)90741-6","article-title":"Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction.","volume":"2","author":"Saikku","year":"1988","journal-title":"Lancet"},{"issue":"Suppl. H","key":"10.1016\/j.diagmicrobio.2009.11.011_bib32","first-page":"H1","article-title":"The Copenhagen City Heart Study (\u00d8sterbrounders\u00f8gelsen). Tables with data from the third examination 1991\u20131994.","volume":"3","author":"Schnohr","year":"2001","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.diagmicrobio.2009.11.011_bib33","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1161\/01.CIR.99.21.2733","article-title":"Relation between direct detection of Chlamydia pneumoniae DNA in human coronary arteries at postmortem examination and histological severity (Stary grading) of associated atherosclerotic plaque","volume":"99","author":"Thomas","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.diagmicrobio.2009.11.011_bib34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0009-8981(99)00236-3","article-title":"Markers of inflammation as predictors in cardiovascular disease","volume":"293","author":"van Lente","year":"2000","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.diagmicrobio.2009.11.011_bib35","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1042\/CS20070298","article-title":"Role of Chlamydia pneumoniae in atherosclerosis","volume":"114","author":"Watson","year":"2008","journal-title":"Clin. Sci."}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889309004738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889309004738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T23:37:23Z","timestamp":1591141043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889309004738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0732889309004738"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2009.11.011","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}